TP53 and neoplasm: These include age; LDH; ECOG performance status; extranodal involvement; and radiomic features such as total metabolic tumor volume (TMTV) and dissemination indices (Dmax and spleen-referenced distances) as well as molecular profiles (CAF, TP53, and mitochondrial gene panels).